Carregant...
Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease
BACKGROUND: Fingolimod is the first oral immunomodulatory therapy approved for highly active relapsing remitting multiple sclerosis. Based on the distribution pattern of fingolimod interacting sphingosine-1-phosphat receptors in organism including immune system and cardiovascular system clinical mon...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2014
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4055797/ https://ncbi.nlm.nih.gov/pubmed/24906818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2377-14-126 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|